Skip to Main Content

Paper Details

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.
Blood
57
2022
Author NameAffiliation
Ran D BalicerClalit Research Institute, Clalit Health Services
Ran D BalicerThe Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute
Ran D BalicerSchool of Public Health, Ben Gurion University of the Negev
  • 1 - 3

Datasets